These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 31484364)
1. Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration. Ishii K; Matsuoka I; Sasaki T; Nishikawa K; Kanda H; Imai H; Hirokawa Y; Iguchi K; Arima K; Sugimura Y J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484364 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation. Ishii K; Sasaki T; Iguchi K; Kajiwara S; Kato M; Kanda H; Hirokawa Y; Arima K; Mizokami A; Sugimura Y Prostate; 2018 Aug; 78(11):849-856. PubMed ID: 29707793 [TBL] [Abstract][Full Text] [Related]
4. Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer. Sasaki T; Ishii K; Iwamoto Y; Kato M; Miki M; Kanda H; Arima K; Shiraishi T; Sugimura Y Lab Invest; 2016 Mar; 96(3):338-49. PubMed ID: 26641067 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
8. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
9. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
10. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Savoy RM; Chen L; Siddiqui S; Melgoza FU; Durbin-Johnson B; Drake C; Jathal MK; Bose S; Steele TM; Mooso BA; D'Abronzo LS; Fry WH; Carraway KL; Mudryj M; Ghosh PM Endocr Relat Cancer; 2015 Jun; 22(3):369-86. PubMed ID: 25759396 [TBL] [Abstract][Full Text] [Related]
11. Castration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft model. Knuuttila M; Yatkin E; Kallio J; Savolainen S; Laajala TD; Aittokallio T; Oksala R; Häkkinen M; Keski-Rahkonen P; Auriola S; Poutanen M; Mäkelä S Am J Pathol; 2014 Aug; 184(8):2163-73. PubMed ID: 24949550 [TBL] [Abstract][Full Text] [Related]
12. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910 [TBL] [Abstract][Full Text] [Related]
13. Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells. Izumi K; Mizokami A J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871130 [TBL] [Abstract][Full Text] [Related]
14. Low androgen sensitivity is associated with low levels of Akt phosphorylation in LNCaP-E9 cells. Iguchi K; Fukami K; Ishii K; Otsuka T; Usui S; Sugimura Y; Hirano K J Androl; 2012; 33(4):660-6. PubMed ID: 22016349 [TBL] [Abstract][Full Text] [Related]
15. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer. Linder A; Larsson K; Welén K; Damber JE Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815 [TBL] [Abstract][Full Text] [Related]
16. Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further. Fujimoto N J UOEH; 2016 Jun; 38(2):129-38. PubMed ID: 27302726 [TBL] [Abstract][Full Text] [Related]
17. [Correlation between the expression of Pim-1 and androgen-deprivation therapy for prostate cancer]. Wang J; Quan CY; Chang WL; Shang ZQ; Jiang N; Li B; Niu YJ Zhonghua Nan Ke Xue; 2015 Sep; 21(9):775-81. PubMed ID: 26552208 [TBL] [Abstract][Full Text] [Related]
18. The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients. Sasaki T; Sugimura Y J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30567361 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis. Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843 [TBL] [Abstract][Full Text] [Related]
20. A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. Pakula H; Xiang D; Li Z Cancers (Basel); 2017 Jan; 9(2):. PubMed ID: 28134791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]